BGM Group Stock
BGM Group Ltd.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- China
- CEO
- Chen Xin
- Employees
- 298
- Market cap
- $110 M
- IPO
- 12/01/2021
Operating from Chengdu, People's Republic of China, BGM Group Ltd. engages in the manufacturing and supply of active pharmaceutical ingredients (APIs), traditional Chinese medicine (TCM) derivatives, and various other related products across China. The company's pharmaceutical portfolio includes an array of…
BGM Group stock: price history
1D
+0.7%
1W
-19.5%
1M
+11.8%
6M
-10.7%
YTD
-92.2%
1Y
-96.9%
2Y
-96.2%
5Y
–
10Y
–
Ask the agents about BGM Group
BGM Group stock metrics
P/E
-1.79
P/B
0.13
EV/EBITDA
-10.75
RETURN ON EQUITY
-0.5%
NET MARGIN
-8.7%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
31/03/2026
Free float & liquidity
FREE FLOAT
22.9%
FLOAT SHARES
2,903,394
AVG. DAILY VOLUME (30D)
5,689
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about BGM Group stock
What does BGM Group do?
BGM Group Ltd. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in China.
The CEO is Chen Xin, the company employs around 298 people.
The IPO was on 12/01/2021; the stock trades on NASDAQ under the ticker BGM.
Does BGM Group pay a dividend?
Yes. The last dividend was US$0.25 per share, ex-date 27/02/2023, paid on 06/03/2023.
The dividend yield is 0.0% (as of 31/03/2026).
Which stocks are comparable to BGM Group?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get BGM Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess BGM Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.